ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Experts Concerned As Phase I Studies Reach Deeper Into Community Practice (Second story in a two-part series.)

April 2, 2010

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

AACR Elion Award Deadline Is Jan. 10

September 16, 1994

ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure

January 24, 2014

HHS plans network of smoking cessation quitlines.

February 6, 2004

Decision On New Division Two-Three Weeks Away: Upton

August 17, 1979